Pharma, IT unable to gain from rupee fall, tariffs bigger worry
Indian IT and pharma stocks are not benefiting from a weaker rupee as expected. Tariff concerns are overshadowing currency gains. Investors are waiting for clarity on trade deals. Foreign investors have also been selling these stocks. Valuations remain a concern for pharma companies. Demand for IT services shows signs of improvement. Stock selection will be […]
Oil explorers surge with global crude after US storm hit
Indian oil explorers surged on Wednesday as global crude prices jumped due to Winter Storm Fern disrupting US output and tightening near-term supply. Oil India and ONGC shares climbed significantly, with the Nifty Oil & Gas Index outperforming broader markets. Analysts noted that stable crude prices directly boost upstream companies’ earnings.
UBS bullish on TaMo CV and Ashok Leyland, assigns ‘Buy’
UBS initiated coverage on Tata Motors’ commercial vehicles business with a buy rating and a ₹550 price target, citing undervaluation compared to global peers. The brokerage also reiterated a buy on Ashok Leyland, raising its price target to ₹225. UBS believes Indian CV makers are poised to narrow valuation gaps due to improving fundamentals.
Rupee hits new low for second time in a week
The Indian rupee fell 31 paise to close at 91.99 against the US dollar on Wednesday, marking its lowest closing level for the second time in under a week. Increased month-end demand for the greenback and ongoing geopolitical tensions weighed on investor sentiment, offsetting an initial stronger opening.